<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150210021034N10</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-30</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of balance-sensory exercises on motor function in patients with MS</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of balance exercises on the textured surface on somatosensory, balance and Spatio-temporal parameters of gait in patients with relapsing-remitting multiple sclerosis: A parallel-groups clinical study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54922</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The samples will be divided into two groups using the blocked randomization method. The choice of this randomization method is according to the sample size of the present study (less than 100 people) to ensure an equal number of people in each group.
Randomization unit: individual
Randomization tool: Random number table
In order to hide random allocation, opaque envelopes sealed and sealed with random sequence are used: In this method, first a random sequence is created using the mentioned method, then based on the sample size of the research, a number of envelopes with aluminum foil (foil) are used. The contents of the envelopes are prepared and each of the random sequences created is recorded on a card and the cards are placed inside the envelopes in the order of placement. In order to maintain a random sequence, the envelopes are numbered in the same way on the outer surface. Finally, the lid of the letter envelopes is glued and placed in a box, respectively. It becomes obvious.
Execution of the random allocation process: One person will create a random sequence, the other person will examine the participants in terms of entry and exit criteria for the study and will register them in the study and the third person will participate in the study, Blinding description: In this study, participants are informed that they are in two groups with different programs, but they are not aware that they are in the intervention or control group.
The outcome assessor and data analyst are also unaware of the allocation of groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Multiple sclerosis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Number: 15 people with multiple sclerosis- Intervention program: Performing balance exercises according to Canadian guidelines Physical activity of adults with multiple sclerosis on a textured surface (material: rubber - 6 mm thick, area 1 in 1.5 m with dentin tissue 3 mm thick And the distance between the dentin 2.5 mm) Duration: 6 weeks (2 one-hour sessions per week). Intervention 2: Control group: Number: 15 people with multiple sclerosis- Intervention program: Performing balance exercises according to Canadian guidelines Physical activity of adults with multiple sclerosis on a tissue-free surface (material: rubber - 6 mm thick, area 1 in 1.5 meters with a tissue-free surface) - Duration: 6 weeks (2 one-hour sessions per week).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The study data (excluding the personal details) can be shred with other researchers or systematic reviewers.

When:
Data will be shared once findings are come up or summary date is published.

To whom:
Data will be shared personally and for academic purposes only.

Conditions:
Data will be shared for teaching or research. Dr Sadeghi (correspondence) will review the requests.

Where to obtain:
People can sent their request to the correspondence and obtain the data.

How to obtain:
Request can be sent through an email (sadeghi@rehab.mui.ac.ir).

Comments:
The kinematic and kinetic information of the gait and data for static balance (forcepate) will be available for researchers who are interested in secondary data analysis.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ebrahim Sadeghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar jerib St</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 5053</telephone>
        <email>sadeghi@rehab.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ebrahim Sadeghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jerib St.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 5053</telephone>
        <email>sadeghi@rehab.mui.ac.ir</email>
        <affiliation>Esfarayen University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of a neurologist
Weakness in somatosensory function based on sensory evaluation
EDSS score 2 to 5.5 (for the ability to perform or complete gait tests according to previous studies)
The ability to walk a distance of 25 feet with or without assistive device
Ability to stand independently for 2 minutes</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The underlying illnesses (such as diabetes and epilepsy) or any problems with neuro-musculoskeletal system other than multiple sclerosis (eg, history of surgery, fracture) disrupts the balance and sensory status
Receive corticosteroid treatment one month before the study
Uncorrected visual disorders
Exacerbation of symptoms
Changes in medications during the study
Attack 30 days before the start of the study or during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G35</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Multiple sclerosis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Number: 15 people with multiple sclerosis- Intervention program: Performing balance exercises according to Canadian guidelines Physical activity of adults with multiple sclerosis on a textured surface (material: rubber - 6 mm thick, area 1 in 1.5 m with dentin tissue 3 mm thick And the distance between the dentin 2.5 mm) Duration: 6 weeks (2 one-hour sessions per week).</i_keyword>
      <i_keyword>Control group: Number: 15 people with multiple sclerosis- Intervention program: Performing balance exercises according to Canadian guidelines Physical activity of adults with multiple sclerosis on a tissue-free surface (material: rubber - 6 mm thick, area 1 in 1.5 meters with a tissue-free surface) - Duration: 6 weeks (2 one-hour sessions per week).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Static balance. Timepoint: Before the intervention, a week after the intervention. Method of measurement: Participants are asked to stand quiet on the force-plate while put the feet together and keep the arms relaxed beside the body. The center of pressure is recorded during 60 second of standing.</prim_outcome>
      <prim_outcome>Dynamic balance. Timepoint: Before the intervention, a week after the intervention. Method of measurement: Timed up and go test: Participants sit on a chair to start the test They are asked to walk with maximum speed during test. They rise with a "go" signal and walk until reach a line at 3 meters distance from the chair then turn and walk back to the chair and sit on it. The time is recorded using a stopwatch.</prim_outcome>
      <prim_outcome>Spatial-temporal parameters of gait. Timepoint: Before the intervention, a week after the intervention. Method of measurement: Walking of participant will be recorded using a motion capture system then parameters of the "gait symmetry" calculated and reported using a Visual 3D software.</prim_outcome>
      <prim_outcome>Somatosensory(sense of joint position). Timepoint: Before the intervention, a week after the intervention. Method of measurement: Ankle proprioception was measured using perception of the inclination whilst participants stood over an adjustable slope box with closed eyes.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Fatigue. Timepoint: Before the intervention, a week after the intervention. Method of measurement: The level of fatigue will be measured using "Fatigue severity scale".</sec_outcome>
      <sec_outcome>Pain. Timepoint: Before the intervention, a week after the intervention. Method of measurement: The participants' pain will be quantified using "Visual analog scale".</sec_outcome>
      <sec_outcome>Spasticity. Timepoint: Before the intervention, a week after the intervention. Method of measurement: Muscle spasticity will be measured using "Modified Ashworth scale".</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-03-03</approval_date>
        <contact_name>Eُthic's committee of Isfahan University of Medical Sciences, Isfahan, Iran</contact_name>
        <contact_address>Hezar Jerib St. Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
